EIRGENIX INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.5 TWD | -0.72% |
|
+2.87% | -17.91% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 4,647 | 9,700 | 33,476 | 37,428 | 30,748 | 25,258 | - |
| Enterprise Value (EV) 1 | 5,338 | 9,800 | 26,978 | 31,421 | 30,748 | 19,925 | 20,001 |
| P/E ratio | -5.09 x | -8.69 x | -619 x | -324 x | -33.5 x | 75.7 x | 61.1 x |
| Yield | - | - | - | - | - | - | - |
| Capitalization / Revenue | 9.76 x | 9.05 x | 19.7 x | 25.3 x | 30.1 x | 11 x | 9.27 x |
| EV / Revenue | 11.2 x | 9.14 x | 15.9 x | 21.2 x | 30.1 x | 8.72 x | 7.34 x |
| EV / EBITDA | -7.27 x | -12 x | 220 x | -243 x | -38.8 x | 31.7 x | - |
| EV / FCF | -4.48 x | -21.4 x | -137 x | -63.7 x | - | -67.9 x | 1,667 x |
| FCF Yield | -22.3% | -4.67% | -0.73% | -1.57% | - | -1.47% | 0.06% |
| Price to Book | 2.51 x | 5.09 x | 3.21 x | 3.5 x | - | 2.44 x | 2.37 x |
| Nbr of stocks (in thousands) | 169,284 | 206,375 | 300,232 | 304,290 | 305,946 | 306,161 | - |
| Reference price 2 | 27.45 | 47.00 | 111.5 | 123.0 | 100.5 | 82.50 | 82.50 |
| Announcement Date | 29/03/20 | 25/03/21 | 30/03/22 | 20/03/23 | 22/03/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 476.1 | 1,072 | 1,697 | 1,481 | 1,023 | 2,286 | 2,726 |
| EBITDA 1 | -734 | -813.9 | 122.4 | -129.2 | -793.1 | 628 | - |
| EBIT 1 | -847.7 | -986 | -60.52 | -333.4 | -1,032 | 434 | 282 |
| Operating Margin | -178.05% | -91.99% | -3.57% | -22.51% | -100.91% | 18.99% | 10.34% |
| Earnings before Tax (EBT) 1 | -860.9 | -1,041 | -42.39 | -115.2 | -913.6 | 467 | 413 |
| Net income 1 | -860.9 | -1,042 | -42.58 | -115.5 | -915.2 | 332 | 413 |
| Net margin | -180.83% | -97.19% | -2.51% | -7.8% | -89.49% | 14.52% | 15.15% |
| EPS 2 | -5.390 | -5.410 | -0.1800 | -0.3800 | -3.000 | 1.090 | 1.350 |
| Free Cash Flow 1 | -1,192 | -457.4 | -196.6 | -493.3 | - | -293.5 | 12 |
| FCF margin | -250.4% | -42.68% | -11.58% | -33.31% | - | -12.84% | 0.44% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | 2.91% |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 29/03/20 | 25/03/21 | 30/03/22 | 20/03/23 | 22/03/24 | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 423.5 | 361.5 | 336.6 | 361.6 | 421.3 | 216.3 | 138.3 | 211.5 | 456.6 | 219.7 | 380 | 712.5 | 735.5 |
| EBITDA 1 | 54.15 | 12.95 | -35.58 | -89.36 | -17.24 | -162.9 | -198.3 | -141.4 | - | -141 | 118 | 156 | 512 |
| EBIT 1 | 7.657 | -35.19 | -85.45 | -141.8 | -71.01 | -220.5 | -255.9 | -199.4 | -356.2 | -214 | -88 | 215 | 196.5 |
| Operating Margin | 1.81% | -9.73% | -25.39% | -39.2% | -16.85% | -101.91% | -185.03% | -94.29% | -78.02% | -97.42% | -23.16% | 30.18% | 26.72% |
| Earnings before Tax (EBT) 1 | 2.182 | 14.19 | 6.787 | -27.16 | -109 | -203.2 | -193.6 | -111.3 | -405.5 | -103.6 | -66.5 | 237 | 214 |
| Net income 1 | 3.094 | 13.85 | 6.418 | -27.56 | -108.2 | -203.5 | -194.1 | -111.7 | -405.9 | -104 | -75 | 224.5 | 167 |
| Net margin | 0.73% | 3.83% | 1.91% | -7.62% | -25.69% | -94.07% | -140.3% | -52.84% | -88.91% | -47.35% | -19.74% | 31.51% | 22.71% |
| EPS 2 | 0.0200 | 0.0500 | 0.0200 | -0.0900 | -0.3600 | -0.6700 | -0.6400 | -0.3700 | -1.330 | -0.3400 | -0.2450 | 0.7400 | 0.5500 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 30/03/22 | 13/05/22 | 12/08/22 | 11/11/22 | 20/03/23 | 15/05/23 | 09/08/23 | 13/11/23 | 22/03/24 | 15/05/24 | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | 691 | 100 | - | - | - | - | - |
| Net Cash position 1 | - | - | 6,498 | 6,006 | - | 5,333 | 5,257 |
| Leverage (Debt/EBITDA) | -0.941 x | -0.1233 x | - | - | - | - | - |
| Free Cash Flow 1 | -1,192 | -457 | -197 | -493 | - | -294 | 12 |
| ROE (net income / shareholders' equity) | -43.7% | -55.4% | -0.69% | -1.09% | - | 3.3% | 3.9% |
| ROA (Net income/ Total Assets) | -26.9% | -28.7% | -0.56% | -0.99% | - | 2.9% | 3.6% |
| Assets 1 | 3,197 | 3,626 | 7,638 | 11,644 | - | 11,448 | 11,472 |
| Book Value Per Share 2 | 11.00 | 9.230 | 34.70 | 35.10 | - | 33.80 | 34.80 |
| Cash Flow per Share 2 | -4.630 | -2.180 | -0.1300 | -0.4900 | - | 1.320 | - |
| Capex 1 | 408 | 38.1 | 167 | 346 | - | 457 | 612 |
| Capex / Sales | 85.71% | 3.56% | 9.82% | 23.35% | - | 19.97% | 22.45% |
| Announcement Date | 29/03/20 | 25/03/21 | 30/03/22 | 20/03/23 | 22/03/24 | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
82.5
TWD
Average target price
132.5
TWD
Spread / Average Target
+60.61%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -17.91% | 790M | |
| -3.05% | 90.45B | |
| +3.95% | 41.45B | |
| -10.51% | 33.57B | |
| +60.58% | 25.73B | |
| -20.09% | 14.73B | |
| -8.92% | 12.82B | |
| -11.46% | 11.7B | |
| -43.05% | 11.44B | |
| +5.17% | 8.79B |
- Stock Market
- Equities
- 6589 Stock
- Financials EirGenix Inc.
